ALG advises Icon on its proposed acquisition of PRA Health Sciences
A&L Goodbody is pleased to be advising longstanding client Icon plc, alongside Cahill Gordon & Reindel, on its proposed acquisition of PRA Health Sciences in a cash and stock transaction valued at approximately $12bn. Icon plc is based out of Dublin and is a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations.
The ALG team includes Mark Ward (Head of M&A), Berni Hosty, Richard Marron, Keavy Ryan, Phil Fogarty and Barry O'Fiachain (Corporate and M&A); Seamus O 'Croinin and Lisa Tait (Finance); Alan McCarthy and Anna Marie Curran (Antitrust) and Paul Fahy and Stephen Egan (Tax).
To view the Irish Times article click here.
Date published: 25 February 2021